Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Electra Therapeutics has raised $183 million in a Series C financing co-led by EQT Life Sciences and Nextech, with participation from Sanofi and other investors, to advance its immunology and cancer programs.
Hyro has secured $45 million in strategic growth funding led by Healthier Capital, with participation from Norwest, Define Ventures, and others. The investment will accelerate the deployment of its AI agents across healthcare systems and expand its Proactive Px platform.
DrugBank has named Lisa Downey as its new CEO, with Co-Founder Mike Wilson transitioning to Chief Product Officer to focus on AI and data intelligence initiatives.
Lightbeam Health Solutions announced that its clients in the Medicare Shared Savings Program generated over $444 million in gross savings during 2024, outperforming national averages in both cost reduction and quality scores.
Brook.ai has appointed former Teladoc Health COO Mike Waters as Chairman of the Board as the company expands its commercial operations and partnerships across health systems.
Tri-City Cardiology has broadened its partnership with Basata to integrate AI-powered voice agents into patient communication, further embedding artificial intelligence into its healthcare operations.
Family Health Choice has announced a partnership with MediKarma to integrate MediKarma's Agentic AI platform into its services, offering members personalized wellness tools and proactive care support starting November 1, 2025.
Alethios has launched a software platform designed to make structured, outcomes-based human health research more accessible. The platform includes tools for study design, recruitment, and management, using generative AI to streamline processes that traditionally take months.
Google Research has unveiled DeepSomatic, an AI model designed to identify cancer-related genetic mutations in tumor cells. The tool uses convolutional neural networks to improve accuracy across multiple sequencing technologies and is now openly available to the research community.
Google and Yale University have introduced C2S-Scale 27B, a 27-billion-parameter AI model for detailed single-cell analysis. The system has shown potential in identifying drug interactions that could support cancer immunotherapy.
Infosys has secured a 15-year, £1.2 billion contract from the NHS Business Services Authority to develop the Future NHS Workforce Solution, replacing the current Electronic Staff Record system for 1.9 million employees across England and Wales.
emtelligent has introduced its next-generation Medical Language Engine, combining document AI, clinical data extraction, and chart review into an integrated platform for healthcare organizations.
Breakthrough Genomics presented its largest interpreted literature database and new AI capabilities for genomic interpretation at the American Society of Human Genetics Annual Meeting in Boston.
Lecturio has acquired SimTutor, a provider of interactive healthcare simulations, to expand its global digital training portfolio and strengthen experiential learning offerings.
Google DeepMind’s biological AI system has identified Senhwa Biosciences’ investigational drug Silmitasertib (CX-4945) as a promising molecule for enhancing immune response against tumors, according to a press release. The discovery, developed with Yale University, was experimentally validated and may open a new path in cancer immunotherapy.
Collette Health has integrated Vonage’s video capabilities into its virtual care platform to improve patient safety and clinical workflows. The partnership uses Vonage’s Video API to support virtual nursing, remote monitoring, and AI-powered risk detection.
Qualio has announced the general availability of Compliance Intelligence, an AI-driven feature within its platform designed to automate gap analysis and continuous compliance monitoring for life sciences companies.
Regard announced a collaboration with Microsoft to integrate its Proactive Documentation platform with Dragon Copilot, enabling clinicians to access diagnostic insights directly through the AI assistant.
Benchling has announced a partnership with Anthropic to integrate its Claude AI models into Benchling’s life sciences platform, enabling scientists to query and analyze research data using natural language.
Zero Candida Technologies has completed the design freeze and started prototype production of its AI-driven therapeutic device ZC-001 for treating Vulvo-Vaginal Candidiasis, with 50 units expected by early 2026.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
